Skip to main content

Table 1 Basic characteristics of included studies in the systematic review

From: Clinical efficacy of enhanced recovery after surgery (ERAS) program in patients undergoing radical prostatectomy: a systematic review and meta-analysis

Author Country Design ERAS group/control group Operation Age (year) PSA (ng/ml) BMI
ERAS group Control group ERAS group Control group ERAS group Control group
Magheli et al. [12] Germany RCT 25/25 LRP 61.8 ± 4.7 61.9 ± 7 7.2 ± 4.9 10.3 ± 8.6 / /
Ren et al. [15] China RCT 9/9 LRP 69.2 12 / /
Huang et al. [10] China Retrospective cohort study 36/37 RALP 62.1 ± 6.9 63.5 ± 7.4 13.44 ± 8.01 15.4 ± 10.59 23.1 ± 2.1 23.5 ± 2.2
Pan and Li [14] China RCT 50/50 LRP 69.3 ± 7.32 / / / /
Yu and Wang [16] China RCT 26/25 RALP 67.65 ± 7.37 72.00 ± 6.07 31.55 ± 22.57 31.35 ± 31.46 21.88 ± 2.49 20.84 ± 3.15
Dong et al. [13] China RCT 109/95 RALP/LRP 66.76 ± 5.83 66.95 ± 5.70 / / 22.39±1.47 22.32 ± 1.54
Lin et al. [11] China Retrospective cohort study 124/164 LRP 70.9 ± 3.6 70 ± 4.3 44.5 ± 22.3 36.8 ± 23.2 20.3 ± 1.5 20.4 ± 1.4
  1. RCT randomized controlled trial, LRP laparoscopic radical prostatectomy, RALP robot-assisted laparoscopic prostatectomy, PSA prostate specific antigen, BMI body mass index